Sr. Director of Business Development
Michael Kranda joined the Allen Institute in 2016. As the Senior Director of Business Development, he is responsible for developing translational and applied research initiatives. His association with the Institute dates to 2003 when he served on the initial Allen Institute for Brain Science board of directors.
Prior to joining the Allen Institute, Kranda served in several senior roles as CEO, President, COO, and the Director of investors representative for multiple public and private biotech companies including Immuex (now Amgen), Oxford GlycoSciences, Vulcan Capital’s Life Sciences Investment Group, and PTC Therapeutics with a focus on business and corporate development, operations, manufacturing, finance, collaborations and M&A.
A native of Seattle, Kranda holds BA and MBA degrees in finance from the University of Washington.